Menu
Back to User profile » Dr David L. Cooper
Papers published by Dr David L. Cooper:
Psychosocial Impact and Disease Management in Patients with Congenital Factor VII Deficiency
Peltier S, Kellum A, Brewer J, Duncan A, Cooper DL, Saad H
Journal of Blood Medicine 2020, 11:297-303
Published Date: 11 September 2020
Disease Burden in Patients with Glanzmann’s Thrombasthenia: Perspectives from the Glanzmann’s Thrombasthenia Patient/Caregiver Questionnaire
Duncan A, Kellum A, Peltier S, Cooper DL, Saad H
Journal of Blood Medicine 2020, 11:289-295
Published Date: 11 September 2020
Population Pharmacokinetic Modeling Of On-Demand And Surgical Use Of Nonacog Beta Pegol (N9-GP) And rFIXFc Based Upon The paradigm 7 Comparative Pharmacokinetic Study
Simpson ML, Kulkarni R, Escuriola Ettingshausen C, Medom Meldgaard R, Cooper DL, Klamroth R
Journal of Blood Medicine 2019, 10:391-398
Published Date: 13 November 2019
Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC)
Rajpurkar M, Croteau SE, Boggio L, Cooper DL
Journal of Blood Medicine 2019, 10:335-340
Published Date: 18 September 2019
Correlations between patient-reported outcomes and self-reported characteristics in adults with hemophilia B and caregivers of children with hemophilia B: analysis of the B-HERO-S study
Buckner TW, Sidonio Jr R, Witkop M, Guelcher C, Cutter S, Iyer NN, Cooper DL
Patient Related Outcome Measures 2019, 10:299-314
Published Date: 18 September 2019
Mild-severe hemophilia B impacts relationships of US adults and children with hemophilia B and their families: results from the B-HERO-S study
Cutter S, Guelcher C, Hunter S, Rotellini D, Dunn S, Cooper DL
Patient Related Outcome Measures 2019, 10:257-266
Published Date: 16 August 2019
Hemophilia and sexual health: results from the HERO and B-HERO-S studies
Blamey G, Buranahirun C, Buzzi A, Cooper DL, Cutter S, Geraghty S, Saad H, Yang R
Patient Related Outcome Measures 2019, 10:243-255
Published Date: 14 August 2019
Efficacy of EHL N9-GP for on-demand treatment of bleeding episodes in hemophilia B: analysis of pivotal trial data
Escobar MA, Walsh CE, Cooper DL, Young G
Journal of Blood Medicine 2019, 10:243-250
Published Date: 25 July 2019
Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency
Rajpurkar M, Cooper DL
Journal of Blood Medicine 2018, 9:227-239
Published Date: 29 November 2018
Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic
Jain S, Donkin J, Frey MJ, Peltier S, Gunawardena S, Cooper DL
Journal of Blood Medicine 2018, 9:211-218
Published Date: 19 November 2018
Evaluation of bleeding disorders in patients with Noonan syndrome: a systematic review
Nugent DJ, Romano AA, Sabharwal S, Cooper DL
Journal of Blood Medicine 2018, 9:185-192
Published Date: 23 October 2018
Educational needs of hematologists and laboratory professionals regarding factor activity assays
Adcock DM, Rasulnia M, Holot N, Cooper DL
Journal of Blood Medicine 2018, 9:51-59
Published Date: 13 April 2018
Internal consistency and item-total correlation of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adult people with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study
Wang M, Batt K, Kessler C, Neff A, Iyer NN, Cooper DL, Kempton CL
Patient Preference and Adherence 2017, 11:1831-1839
Published Date: 25 October 2017
Known-group validity of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study
Buckner TW, Wang M, Cooper DL, Iyer NN, Kempton CL
Patient Preference and Adherence 2017, 11:1745-1753
Published Date: 11 October 2017
Reliability of patient-reported outcome instruments in US adults with hemophilia: the Pain, Functional Impairment and Quality of life (P-FiQ) study
Kempton CL, Wang M, Recht M, Neff A, Shapiro AD, Soni A, Kulkarni R, Buckner TW, Batt K, Iyer NN, Cooper DL
Patient Preference and Adherence 2017, 11:1603-1612
Published Date: 19 September 2017
Identification of patients with congenital hemophilia in a large electronic health record database
Wang M, Cyhaniuk A, Cooper DL, Iyer NN
Journal of Blood Medicine 2017, 8:131-139
Published Date: 30 August 2017
Construct validity of patient-reported outcome instruments in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study
Batt K, Recht M, Cooper DL, Iyer NN, Kempton CL
Patient Preference and Adherence 2017, 11:1369-1380
Published Date: 9 August 2017
Identification of people with acquired hemophilia in a large electronic health record database
Wang M, Cyhaniuk A, Cooper DL, Iyer NN
Journal of Blood Medicine 2017, 8:89-97
Published Date: 19 July 2017
A global quantitative survey of hemostatic assessment in postpartum hemorrhage and experience with associated bleeding disorders
James AH, Cooper DL, Paidas MJ
International Journal of Women's Health 2017, 9:477-485
Published Date: 3 July 2017
Recognition and management of platelet-refractory bleeding in patients with Glanzmann’s thrombasthenia and other severe platelet function disorders
Chitlur M, Rajpurkar M, Recht M, Tarantino MD, Yee DL, Cooper DL, Gunawardena S
International Journal of General Medicine 2017, 10:95-99
Published Date: 3 April 2017
Hemostatic assessment, treatment strategies, and hematology consultation in massive postpartum hemorrhage: results of a quantitative survey of obstetrician-gynecologists
James AH, Cooper DL, Paidas MJ
International Journal of Women's Health 2015, 7:873-881
Published Date: 4 November 2015
Associations of quality of life, pain, and self-reported arthritis with age, employment, bleed rate, and utilization of hemophilia treatment center and health care provider services: results in adults with hemophilia in the HERO study
Forsyth AL, Witkop M, Lambing A, Garrido C, Dunn S, Cooper DL, Nugent DJ
Patient Preference and Adherence 2015, 9:1549-1560
Published Date: 29 October 2015
Mixing and administration times of bypassing agents: observations from the Dosing Observational Study in Hemophilia (DOSE)
Maahs J, Donkin J, Recht M, Cooper DL
Journal of Blood Medicine 2014, 5:153-156
Published Date: 20 August 2014
A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project
Lentz SR, Tandra A, Gut RZ, Cooper DL
Journal of Blood Medicine 2014, 5:1-3
Published Date: 13 January 2014
Capturing daily assessments and home treatment of congenital hemophilia with inhibitors: design, disposition, and implications of the Dosing Observational Study in Hemophilia (DOSE)
Young G, Solem CT, Hoffman K, Kabawat J, Pickard AS, Gut RZ, Cooper DL
Journal of Blood Medicine 2012, 3:131-138
Published Date: 7 November 2012
Barriers to effective diagnosis and management of a bleeding patient with undiagnosed bleeding disorder across multiple specialties: results of a quantitative case-based survey
Reding MT, Cooper DL
Journal of Multidisciplinary Healthcare 2012, 5:277-287
Published Date: 26 October 2012